Jump Financial LLC Purchases Shares of 12,969 Balchem Co. (NASDAQ:BCPC)

Jump Financial LLC acquired a new stake in Balchem Co. (NASDAQ:BCPC) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 12,969 shares of the basic materials company’s stock, valued at approximately $2,114,000.

Other large investors also recently modified their holdings of the company. Quadrant Capital Group LLC raised its holdings in shares of Balchem by 8.2% in the 4th quarter. Quadrant Capital Group LLC now owns 989 shares of the basic materials company’s stock valued at $161,000 after acquiring an additional 75 shares in the last quarter. Covestor Ltd increased its stake in Balchem by 93.8% in the fourth quarter. Covestor Ltd now owns 157 shares of the basic materials company’s stock valued at $26,000 after acquiring an additional 76 shares during the last quarter. Arizona State Retirement System raised its position in Balchem by 0.8% during the fourth quarter. Arizona State Retirement System now owns 9,413 shares of the basic materials company’s stock valued at $1,534,000 after purchasing an additional 77 shares in the last quarter. Mariner LLC lifted its stake in Balchem by 3.8% during the fourth quarter. Mariner LLC now owns 2,595 shares of the basic materials company’s stock worth $423,000 after purchasing an additional 94 shares during the last quarter. Finally, Summit Investment Advisors Inc. boosted its holdings in shares of Balchem by 3.3% in the 4th quarter. Summit Investment Advisors Inc. now owns 3,382 shares of the basic materials company’s stock worth $551,000 after purchasing an additional 107 shares in the last quarter. 87.91% of the stock is owned by institutional investors.

Analyst Ratings Changes

BCPC has been the subject of a number of recent research reports. StockNews.com downgraded Balchem from a “buy” rating to a “hold” rating in a research report on Tuesday, February 25th. Sidoti raised shares of Balchem to a “hold” rating in a report on Tuesday, February 25th. Finally, HC Wainwright reissued a “buy” rating and issued a $190.00 price target on shares of Balchem in a research note on Monday, February 24th.

Balchem Price Performance

Shares of Balchem stock opened at $161.50 on Friday. The stock has a market capitalization of $5.25 billion, a P/E ratio of 41.09, a price-to-earnings-growth ratio of 4.41 and a beta of 0.75. Balchem Co. has a one year low of $137.69 and a one year high of $186.03. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.99 and a quick ratio of 1.16. The business’s 50 day simple moving average is $164.84 and its two-hundred day simple moving average is $167.72.

Balchem (NASDAQ:BCPC) last released its quarterly earnings data on Friday, February 21st. The basic materials company reported $1.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.11 by ($0.08). The firm had revenue of $240.00 million during the quarter, compared to analysts’ expectations of $239.96 million. Balchem had a net margin of 13.47% and a return on equity of 11.37%. Analysts forecast that Balchem Co. will post 4.64 EPS for the current year.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.